跳至主要内容
临床试验/CTRI/2024/06/069464
CTRI/2024/06/069464尚未招募3 期

PHARMACOGNOSTICAL AND PHARMACO-THERAPEUTIC EVALUATION OF KATPHALA(Myrica esculenta Buch-Ham)TWAK IN THEMANAGEMENT OF PRAMEHA(TYPE 2 DIABETES MELLITUS) - NI

Post Graduate Institute of Ayurveda DSRRAU Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients between the age group of 30-70 years of either sex present with clinical
  • features of Prameha. 2. Patients having a fasting blood sugar level (FBS) greater than 126 mg/dL and less than 200 mg/dL. 3. Patients having a 2 hour post prandial blood sugar level (PPBS) greater than 200 mg/dL and less than 350 mg/dL. 4. Written consent showing willingness to participate in the study.

排除标准

  • 1. Patients below 30 years and above 70 years will be excluded. 2. Pregnant and lactation mothers. 3. Known case of Type 1 Diabetes Mellitus or I. D. D. M. Patients. 4. Type 2 DM patients having insulin therapy due to secondary failure. 5. Patients suffering from the complications of DM like Ketoacidosis, Neuropathy, Nephropathy, Retinopathy and Diabetic wounds. 6. Patients suffering from any severe systemic disease, chronic infections or any active malignancy.

研究者

发起方
Post Graduate Institute of Ayurveda DSRRAU Jodhpur

相似试验